Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.41 |
| ▸ | AGXT | P21549 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.36 |
| ▸ | KLK1 | P06870 | 2/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27113249 | 0.83 | AGXT (0.57) | PRMT6ITGB3ITGA2BAGXTLMNA | |
| SCHEMBL27114131 | 0.80 | ITGB3 (0.46) | PRMT6ITGB3ITGA2BAGXTLMNA | |
| SCHEMBL27120294 | 0.80 | PRMT6 (0.46) | PRMT6ITGB3ITGA2BAGXTLMNA | |
| SCHEMBL27113417 | 0.80 | PRMT6 (0.46) | PRMT6ITGB3ITGA2BAGXTLMNA | |
| SCHEMBL27113243 | 0.78 | PRMT6 (0.47) | PRMT6ITGB3ITGA2BAGXTLMNA | |
| SCHEMBL27113244 | 0.78 | HTR7 (0.49) | PRMT6ITGB3ITGA2BMAPTHTT | |
| SCHEMBL27118870 | 0.77 | PRMT6 (0.46) | PRMT6ITGB3ITGA2BAGXTLMNA | |
| SCHEMBL27116714 | 0.74 | F2 (0.41) | ITGB3ITGA2BLMNAMEN1KMT2A | |
| SCHEMBL27113245 | 0.73 | SMN1; SMN2 (0.53) | ITGB3ITGA2BLMNAMEN1KMT2A | |
| SCHEMBL27116713 | 0.73 | ITGB3 (0.43) | PRMT6ITGB3ITGA2BLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066135-A1 | DRUG CONJUGATES AND USES THEREOF | SUPERTRANS MEDICAL LTD (IL) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066135-A1 | DRUG CONJUGATES AND USES THEREOF | SLC7A1, ABCB11, SLC1A5 | PRMT6 1447/4885ITGB3 475/4885ITGA2B 1099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.